Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.5 RB, SLA? 10mm, RXD: medical device reports filed with FDA

1,865 reports name it, 2020–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,865
device reports naming the brand
0% of all MAUDE reports · about 316 a year
607
reports, 12 months to August 2026
512 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,865 medical device reports received by FDA name the brand "BLX ?3.5 RB, SLA? 10mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from August 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

607 reports arrived in the 12 months to August 2026, up 19% from 512 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (73%), loss of osseointegration (18.8%) and difficult to insert (0.9%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

057114Sep 2021: 1Oct 2021: 6Nov 2021: 5Dec 2021: 102022Jan 2022: 9Feb 2022: 4Mar 2022: 11Apr 2022: 15May 2022: 13Jun 2022: 7Jul 2022: 8Aug 2022: 20Sep 2022: 8Oct 2022: 26Nov 2022: 21Dec 2022: 242023Jan 2023: 13Feb 2023: 26Mar 2023: 20Apr 2023: 26May 2023: 24Jun 2023: 15Jul 2023: 20Aug 2023: 27Sep 2023: 13Oct 2023: 18Nov 2023: 12Dec 2023: 322024Jan 2024: 22Feb 2024: 32Mar 2024: 35Apr 2024: 34May 2024: 41Jun 2024: 32Jul 2024: 45Aug 2024: 31Sep 2024: 36Oct 2024: 40Nov 2024: 45Dec 2024: 352025Jan 2025: 32Feb 2025: 37Mar 2025: 45Apr 2025: 30May 2025: 0Jun 2025: 114Jul 2025: 61Aug 2025: 37Sep 2025: 42Oct 2025: 53Nov 2025: 52Dec 2025: 602026Jan 2026: 39Feb 2026: 37Mar 2026: 74Apr 2026: 47May 2026: 49Jun 2026: 60Jul 2026: 60Aug 2026: 34

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02825632020: 320202021: 5920212022: 16620222023: 24620232024: 42820242025: 56320252026: 4002026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,865
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report80.2%1,495
Voluntary report0%0
User facility report0%0
Distributor report19.8%370
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,36173%62.8%
Loss of osseointegration35118.8%22.4%
Difficult to insertthe device was hard to insert170.9%0.4%
Fracturea broken bone30.2%1.6%
Separation failure20.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis66535.7%
Painpain, site not specified34018.2%
Inflammationinflammation1528.2%
Hemorrhage/blood loss/bleeding1075.7%
Swelling/ edema1015.4%
Fistula532.8%
Abscessa collection of pus482.6%
Hyperresponsive to stimuli472.5%
Hypersensitivity/allergic reaction281.5%
Sinus perforation30.2%
Numbnessnumbness10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.5 RB, SLA? 10mm, RXDProduct code DZEAll MAUDE reports
Reports1,8653,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer80.2%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.5 RB, SLA? 10mm, RXD reports

How many FDA reports name BLX ?3.5 RB, SLA? 10mm, RXD?

1,865 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 607 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (73%), loss of osseointegration (18.8%), difficult to insert (0.9%), fracture (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (80.2%) and distributor reports (19.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.5 RB, SLA? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.